April 2014

Did you know? Women are 37% more likely to have COPD than men. Once considered a “man’s disease” COPD is now far more prevalent in women. On the blog this month, we take a closer look at why women are more commonly affected. Keep reading to learn more.

Lastly, are you sleeping well? Approximately 50 percent of COPD patients report significant sleep disturbances. If you fall in this category, it’s important to speak to your doctor! Check out our 7 tips to help you get a restful night’s sleep.

Have you been treated at Lung Institute and would like to share your treatment story? We would love to feature you in our next edition.
Contact us at info@lunginstitute.com.


COPD in Women

You may be surprised to hear that COPD is more common in women. In fact, women are 37% more likely to have COPD than men. Women also account for more than half of all deaths attributed to COPD in the United States. Women are at a higher risk for COPD than men.

COPD was once considered a “man’s disease.” It seemed like it struck older, white men more than any other group. American soldiers were given cigarettes in their rations for years, and well-known images of the Marlboro Man reinforced the link between men and smoking.

Read more

7 Things You Need to Know about Sleep  and COPD

If you have COPD, you know that difficulty breathing isn’t just limited to the daytime and often gets in the way of falling asleep. This can lead to mild fatigue and in severe cases debilitating exhaustion. People with COPD are more likely to develop insomnia, nightmares, and daytime sleepiness when compared to the general population. Approximately 50 percent of COPD patients report significant sleep disturbances. If you fall in this category it’s important to address your sleep disturbance immediately.

Read more

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.